March 10, 2025 · Form 4 insider transaction
Chambers Michael Andrew bought 4,792 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.